|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| Market Cap | 63.66B 57.98B 53.43B 48.6B 91.17B 5,895B 95.82B 650B 258B 3,220B 239B 234B 10,105B | P/E 2018 |
-8.76x | P/E 2019 | -11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 80.96B 73.74B 67.95B 61.81B 116B 7,497B 122B 827B 329B 4,095B 304B 297B 12,852B | EV / Sales 2018 |
4.24x | EV / Sales 2019 | 4.98x |
| Free-Float |
99.9% | Yield 2018 |
2.15% | Yield 2019 | 1.55% |
| Manager | Title | Age | Since |
|---|---|---|---|
Alex Thurman
DFI | Director of Finance/CFO | 56 | 30/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Reents
BRD | Director/Board Member | - | 07/05/2020 |
Ryan Quigley
BRD | Director/Board Member | - | 07/05/2020 |
Andres Rodrigo
BRD | Director/Board Member | - | 07/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +0.33% | -4.76% | +25.01% | +75.64% | 452B | |
| Weighted average by Cap. | +0.30% | -5.19% | +26.02% | +87.88% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 15.79B 14.38B 13.25B 12.05B 22.61B 1,462B 23.76B 161B 64.09B 798B 59.23B 57.99B 2,506B | 16.09B 14.65B 13.5B 12.28B 23.04B 1,490B 24.22B 164B 65.32B 814B 60.37B 59.09B 2,554B |
| Net income | -5.1B -4.64B -4.28B -3.89B -7.3B -472B -7.67B -52.06B -20.69B -258B -19.12B -18.72B -809B | -5.27B -4.8B -4.42B -4.02B -7.55B -488B -7.93B -53.84B -21.4B -267B -19.78B -19.36B -837B |
| Net Debt | 21.89B 19.94B 18.37B 16.71B 31.35B 2,027B 32.95B 224B 88.87B 1,107B 82.13B 80.4B 3,475B | 17.3B 15.76B 14.52B 13.21B 24.78B 1,602B 26.05B 177B 70.25B 875B 64.93B 63.56B 2,747B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















